2009
DOI: 10.1016/s1098-3015(10)74330-8
|View full text |Cite
|
Sign up to set email alerts
|

Pcn79 Cost-Effectiveness Evaluation of the Use of Capecitabine+docetaxel vs Gemcitabine+docetaxel in Patients With Recurrent Breast Cancer Who Previously Failed to Anthracycline Chemotherapy and/or With Metastatic Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance